Oncomed Pharmaceuticals
OMED · Chemicals & Drugs · NASDAQ · in our data July 18, 2013 to April 22, 2019 (5.8 years)
The first trading day in our data for Oncomed Pharmaceuticals is July 18, 2013 (its first day in our records, which may be later than its listing and is not its founding). At its peak, on March 20, 2014, the market valued it at $1.1 billion. It ended in a collapse: the last trade was $0.89, -97.7% from its split-adjusted high. The delisting record says: merged or acquired.
Share prices are adjusted for splits and other share changes, so the high and the last price compare like for like; the peak market value is as it was on the day. The return covers the trading days in our data only: it does not include what holders received, or lost, after the last trade (a merger payout, a bankruptcy), and it does not reach back before 2013. How these numbers are made · Report a data issue.
Play today's Daily DropAlso gone in 2019: Chemicals & Drugs
- Celgene peaked at $115.3 billion
- Array Biopharma Inc peaked at $10.6 billion
- Tesaro Inc peaked at $10.2 billion
- Loxo Oncology Inc peaked at $7.2 billion
- Versum Materials Inc peaked at $5.8 billion
- Spark Therapeutics Inc peaked at $4.4 billion
